Skip to main content
. Author manuscript; available in PMC: 2013 May 23.
Published in final edited form as: Genet Med. 2011 Sep;13(9):777–784. doi: 10.1097/GIM.0b013e31822c79f9

Table 3.

Case-control analysis of recurrent deletions

Deleted Region Initial Call Final Call Cases Controls OR Lower 95% CI Upper 95% CI p-value Itsara et al. Study
22q11.2 pCNV pCNV 93 0 15.96 9.15E-21 7.93E-09
16p11.2 pCNV pCNV 67 5 8.64 3.52 27.49 6.34E-10 0.186
1q21.1 pCNV pCNV 55 3 11.82 3.84 59.07 5.38E-09 1.67E-04
15q13.2-q13.3 BP4-BP5 pCNV pCNV 46 0 7.71 1.44E-10 1.08E-05
15q11.2-q13 BP2-BP3 pCNV pCNV 41 0 6.84 2.77E-09
7q11.23 pCNV pCNV 34 0 5.62 8.49E-08
16p13.11 pCNV pCNV 22 3 4.72 1.42 24.62 0.0063
17q21.31 pCNV pCNV 22 0 3.52 2.49E-05
17q12 pCNV pCNV 18 0 2.83 0.00015
1q21 pCNV pCNV 17 1 10.93 1.71 456.06 0.0026 *
17p11.2 pCNV pCNV 16 0 2.48 0.00045
8p23.1 pCNV pCNV 10 0 1.44 0.0084
3q29 pCNV pCNV 9 0 1.27 0.0147 0.164
5q35 pCNV pCNV 8 0 1.10 0.026

Itsara et al. performed a meta-analysis of segmental duplication-mediated regions on 6860 cases and 5674 controls. For regions in common, the p-value assessing the difference in CNV frequency between the cases and controls was included.

*

The 1q21 and 1q21.1 regions were combined in the Itsara et al. analysis.